There are also some promising targeted therapies probably providing an effective medical intervention strategy for the control of obesity-related asthma, such as microRNAs, TLR antagonists, and biologics of IL-1 and IL-6 (Ortega et al., 2014). This evidence concerns the gene IL1B and obesity due to melanocortin 4 receptor deficiency.